ITGAM and neoplasm: A series of experiments to assess peritoneal macrophage chemoattraction to the tumor site revealed that both treatments stimulated an increase in the level of cells with CD11b+Ly-6C+ markers in the peritoneal macrophage population of treated animals from both groups, similar to the results of peritoneal macrophage activation by GcMAF-RF alone in intact animals.